CML patient samples were investigated for the presence of myeloid-derived suppressor cells (MDSCs), expression of programmed death receptor ligand 1/programmed death receptor 1 (PD-L1/PD-1), arginase 1 and soluble CD25. This evidence concerns the gene ARG1 and chronic myelogenous leukemia, BCR-ABL1 positive.